View the Abstracts online

 Late Breaking Abstract Submission now closed
  1. Recommendations for Poster Presentations
  2. Recommendations for Speakers and Oral Presenters
  1. IMPORTANT DATES
    Submissions accepted from: 18 April 2011
    Deadline for submissions: 23 June 2011
    Notification of Acceptance: Mid July 2011

    Abstracts received after the deadline will not be accepted!

  1. TECHNICAL REQUIREMENTS

  • The internet abstract submission system works best with Internet Explorer 7.0 or higher and Mozilla Firefox 3.0 or higher

  • Cookies and JavaScript needs to be enabled

  1. GENERAL

Abstracts sent by post or email will not be accepted. No exceptions will be made.

  • The abstract must not have already been submitted for and presented at another meeting.

  • For standardization, the acceptable length of the abstract is of maximum 2.500 characters. This includes the author’s details, titles and non-visible characters, such as spaces and line breaks.

  • Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline (23 June 2011, midnight CET). Therefore, the submitter will be required to create a user account.

  • Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the conference.

  • The submitted / draft abstracts cannot be edited after the submission deadline

  • The abstract should be structured into the following sections:

    • A title which clearly indicates the nature of the investigation
    • Background should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance
    • Methods should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study
    • Results should contain objective data to answer the scientific question(s).
    • Conclusions should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization.
    • References should be provided (if necessary)

  • Conflict of interest: It is the intent of HUPO to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during abstract submission.

  • Abbreviations should be defined.

  • Trade names can be mentioned in the title, as well as in the body of the text.

  • The submission of an abstract constitutes a formal commitment by the submitting (presenting) author to present the abstract (if accepted) in the session and the time assigned by the Scientific Committee. Registration fees will not be waived.

  • The presenting author of the abstract must be registered at the conference.

  • Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proof reading will be done.

  • No changes can be made to the abstract after the submission deadline.

  • The registration fees for the presenting author will not be waived.

  • The submitting authors will be notified by Mid-July 2011 at the email address provided during submission whether their abstract has been accepted.

  • If you need to withdraw your abstract a written statement, reflecting the reasons for this decision must be sent to hupo2011abs@mci-group.com not later than 30 May 2011.

PRESENTATION OF ABSTRACTS

  • Abstracts can be accepted either as poster or oral communication.

  • If your abstract is accepted as a poster, you will be requested to be available for discussion during the corresponding poster viewing session.

  • Details on poster format and full presentation guidelines will be included in the notification letter and posted on the conference website